Aerosolized Calfactant in Infants With RDS: Surfactant Replacement 2.0?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

1. A multicentre neonatal interventional randomised controlled trial of nebulized surfactant for preterm infants with respiratory distress: Neo-INSPIRe trial protocol.BMC pediatrics · 2023
   Article
2. Is aerosolized calfactant effective and safe in the treatment of respiratory distress syndrome?Journal of perinatology : official journal of the California Perinatal Association · 2022
   Article
3. Aerosol drug delivery to spontaneously-breathing preterm neonates: lessons learned.Respiratory research · 2021
   Review

Corrections and comments

• Comment on
  Aerosolized Calfactant for Newborns With Respiratory Distress: A Randomized Trial.2020

Authors and funding

2 authors at 1 institution in 1 country.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as